Export

EN
FR
ATC codes: L01XX05
EMLc
Indication
Other specified sickle cell disorders or other haemoglobinopathies ICD11 code: 3A51.Y
INN
Hydroxycarbamide
Medicine type
Chemical agent
List type
Complementary (EML)
(EMLc)
Formulations
Oral > Solid > dosage form: 200 mg ; 500 mg ; 1 g ; 100 mg (EMLc)
EML status history
First added in 2011 (TRS 965)
Changed in 2023 (TRS 1049)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended the deletion of hydroxycarbamide 250 mg solid oral dosage from the EML and EMLc, and the addition of hydroxycarbamide 100 mg solid oral dosage form to the EMLc.